title: Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance.
authors.forename: G
authors.initials: G
authors.lastname: Sanna
authors.forename: M L
authors.initials: ML
authors.lastname: Bertolaccini
authors.forename: A
authors.initials: A
authors.lastname: Mameli
authors.forename: G R V
authors.initials: GR
authors.lastname: Hughes
authors.forename: M A
authors.initials: MA
authors.lastname: Khamashta
authors.forename: A
authors.initials: A
authors.lastname: Mathieu
mesh_terms: D000328:Adult; D000368:Aged; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D005260:Female; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010718:Phosphatidylserines / Q000276:immunology; D011516:Prothrombin / Q000276:immunology; D012595:Scleroderma, Systemic / Q000276:immunology*; D053482:beta 2-Glycoprotein I
chemical_list: D017152:Antibodies, Antiphospholipid; D006023:Glycoproteins; D010718:Phosphatidylserines; D053482:beta 2-Glycoprotein I; D011516:Prothrombin